Streetbeat News

Analyst Ratings

KVYO

Goldman Sachs analyst Gabriela Borges upgraded Klaviyo Inc (NYSE:KVYO) from Neutral to Buy, maintaining a price target of $36. Despite a 22% underperformance over the past three months, Borges sees 2024 as a pivotal year with three main catalysts: overdone concerns around email spam filtering changes, potential market share gains, and upside to estimates from company-specific drivers and stable consumer spending. Shares of Klaviyo rose 4.8% in premarket trading.

Portfolio Pulse from Priya Nigam

February 05, 2024 | 5:42 pm

FDMT

BMO Capital analyst Kostas Biliouris maintains an Outperform rating on 4D Molecular Therapeutics (NASDAQ:FDMT) and raises the price target from $50 to $70.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:41 pm

CI

Cigna Group (NYSE:CI) shares rose after reporting Q4 results, with analysts upgrading ratings and raising price targets following the company's 2024 guidance. The guidance suggests Evernorth revenues will exceed consensus estimates by $10 billion. Analysts highlight Cigna's strong earnings growth visibility, supported by share repurchases and solid operating conditions. Cigna is named a 'Top Pick for 2024' by Mizuho Securities, citing solid EPS visibility and reduced legislative risk.

Portfolio Pulse from Priya Nigam

February 05, 2024 | 5:39 pm

EVBG

Canaccord Genuity analyst Michael Walkley downgraded Everbridge (NASDAQ:EVBG) from Buy to Hold and set a price target of $28.6.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:30 pm

SKM

Nomura analyst Angela Hong downgrades SK Telecom Co (NYSE:SKM) from Neutral to Reduce, indicating a negative outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:28 pm

KPTI

Traders are closely monitoring Karyopharm Therapeutics (KPTI) following analyst comments suggesting potential acquisition interest from larger cancer companies for its drug Selinexor, in light of the MOR takeover interest.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:23 pm

TSLA

Piper Sandler analyst Alexander Potter maintained an Overweight rating on Tesla, Inc. (NASDAQ:TSLA) but reduced the price target from $295 to $225, citing a lowered 2024 volume estimate from 2.18 million units to 1.93 million units. The reduction is attributed to Tesla's aging product lineup and the prioritization of the Cybertruck over a cheaper, more broadly appealing vehicle. Despite near-term skepticism, Potter remains bullish on Tesla's long-term prospects, highlighting the potential in non-automotive segments like Tesla Energy.

Portfolio Pulse from Shanthi Rexaline

February 05, 2024 | 5:22 pm

JKS

Daiwa Capital analyst Dennis Ip downgraded JinkoSolar Holding Co (NYSE:JKS) from Outperform to Neutral and set a price target of $25. This adjustment reflects a change in the firm's outlook on JinkoSolar's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:19 pm

SINT

Maxim Group analyst Tate Sullivan downgrades SINTX Techs (NASDAQ:SINT) from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:17 pm

CFLT

UBS analyst Karl Keirstead has maintained a Neutral rating on Confluent (NASDAQ:CFLT) and raised the price target from $21 to $26.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 5:14 pm